Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02211 UNI HEALTH
RT Nominal down0.126 -0.004 (-3.077%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others199,807-3.327%213,130221,759290,757247,923
Land & other Lease Assets4,751-12.116%5,6267,44721,640--
Intangible Assets0--0045213,426
Interests in Asso. & JCEs83,06447.974%70,366110,640332,830322,739
Other Non-current Assets119,4841.372%110,217114,677110,785158,883

407,1065.443%399,339454,523756,464742,971
Current Assets
2023/12 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories144,006-12.260%175,150204,824322,078301,502
Trade Receivables83,0143.619%159,782112,181176,936211,136
Cash & Bank Balances35,454-17.539%60,66968,28645,758485,679
Other Current Assets52,628-19.695%66,21464,626116,336137,054
Assets Held for Sale29,908--0000

345,010-2.201%461,815449,917661,1081,135,371
Current Liabilities
2023/12 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables355,4820.936%420,266301,190335,182216,746
S-T Debt & Leases40,00012844.984%2913,84410,22811,231
Other Current Liabilities22,646-27.720%38,49791,48974,63056,466
Liab asso w/ Assets Held for Sale12,114--0000

430,24212.093%459,054396,523420,040284,443
Net Current Assets(85,232)174.473%2,76153,394241,068850,928
Total Assets Less Current Liabilities321,874-9.341%402,100507,917997,5321,593,899
Non-current Liabilities
2023/12 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases0--42,12640,0003,84314,071
Other Non-current Liabilities0--000951

0--42,12640,0003,84315,022
Capital and Reserves
2023/12 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital43,5870.000%35,94329,76424,83324,833
  Reserves278,2422.619%323,659437,449967,5801,550,762
  Others0--0000
Shareholders' Funds321,8292.256%359,602467,213992,4131,575,595
Non-controlling Interests45--3727041,2763,282
Others0--0000

321,8742.271%359,974467,917993,6891,578,877
Commitments and Contingent Liabilities
2023/12 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments------------
Contingent Liabilities------------
Remarks:  Real time quote last updated: 01/11/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 413
%Change--
EPS / (LPS)RMB 0.001
NBV Per Share (¥)RMB 0.440
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.